| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.59B | +6.8% |
| Cost of Revenue | $1.71B | +7.4% |
| Gross Profit | $885.5M | +5.7% |
| R&D Expense | $36.0M | -9.3% |
| SG&A Expense | $533.4M | +4.0% |
| Operating Income | $329.1M | +7.5% |
| Pre-tax Income | $300.3M | -5.9% |
| Income Tax | $69.2M | -14.0% |
| Net Income | $223.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $72.0M | +74.8% |
| Accounts Receivable | $374.3M | -2.4% |
| Inventory | $416.8M | -0.8% |
| Current Assets | $988.7M | +2.6% |
| Total Assets | $3.75B | +8.5% |
| Current Liabilities | $601.6M | +0.8% |
| Long-term Debt | $1.22B | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $214.4M | -14.5% |
| Capital Expenditures | $40.2M | +13.1% |
| Investing Cash Flow | -$184.4M | -423.0% |
| Financing Cash Flow | $7.6M | +103.4% |
| Free Cash Flow | $174.1M | -19.1% |
| -4.8% |
| EPS (Basic) | $3.70 | -5.6% |
| EPS (Diluted) | $3.69 | -5.9% |
| Total Liabilities |
| $2.37B |
| +146.5% |
| Stockholders' Equity | $1.35B | -45.1% |